SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cambridge Antibody Technology Group
An SI Board Since December 1999
Posts SubjectMarks Bans
625 23 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
450I saw an ABT report that seems to say IL-12 P2 in MS has started. Can't conkeokalani'nui-1/22/2004
449NIce to see the stock up over 10% on good volume- Lehman raised from underweightMadharry-1/20/2004
448The standard technique is to PM the founder of the thread and get him to make thtuck-1/20/2004
447would you know how to tie this thread to the quote of catg .so that one can acceMadharry-1/19/2004
446Thanks for posting that Harry. I found it reassuring. EOMA.J. Mullen-1/19/2004
445windhover.com Interesting comment about the legal dispute from july '03Madharry-1/19/2004
444From Abbott's results PR: Q2) How did HUMIRA perform in the fourth qunigel bates-1/16/2004
443<i>Parking the PR for the GENZ/Macrogenics deal last year -</i> Octnigel bates-1/14/2004
442Genzyme to Establish Research Facility in Europe Cambridge, England Chosen for Nnigel bates-1/14/2004
441Re: LymphostatB trial: Human Genome Sciences announced on Thursday, January 8,keokalani'nui-1/12/2004
440Cambridge Antibody Technology: Clinical Trials Update Monday January 12, 7:02 amnigel bates-1/12/2004
439PII started for Lymphostat-B in RA: Message 19667203nigel bates-1/8/2004
438I'm sure it will be more than just the royalties. As Garland said just befonigel bates-1/3/2004
437Baxter and Abbott.... veteran biotech investors would LOVE to see them get whascaram(o)uche-1/3/2004
436If not to a jury at least to a judge. Plus, the same language/interpretation keokalani'nui-1/3/2004
435>> Chiselling ingrates << I haven't been watching. Is there anscaram(o)uche-1/3/2004
434New Year 's biotech nap in the Times. Can't dismiss this out of hand, anigel bates-1/2/2004
433any news today? CAT.L up almost 8% in UK?Madharry-1/2/2004
432I am hopeful that Humira will continue to be wildly successful. How much can CATMadharry-12/31/2003
431Chiselling ingrates... ABBOTT PARK, Ill., Dec. 30 /PRNewswire-FirstCall/ -- HUMnigel bates-12/30/2003
430Cambridge Antibody Technology and Amgen Restructure Existing Agreement Wednesdaynigel bates-12/24/2003
429i added more catg shares hereMadharry-11/20/2003
428Another potential fly in the ointment: Australia's Peptech: Resolves Disputnigel bates-11/19/2003
427Reading Chambre's reported comments in some of today's press, it seems tnigel bates-11/18/2003
426Yup -its about timeMadharry-11/18/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News